{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["antioxidant", "hyperoside", "liver disease", "pharmacological effects"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35892639", "DateRevised": {"Year": "2022", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["1437", "10.3390/antiox11081437"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "11", "Issue": "8", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "25"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases.", "Abstract": {"AbstractText": ["Hyperoside (Hyp), also known as quercetin-3-<i>O</i>-galactoside or 3-<i>O</i>-\u03b2-D-galactopyranosyl, is a well-known flavonol glycoside that is abundant in various fruits, vegetables, and medicinal plants. Hyp has been suggested to exhibit a wide range of biological actions, including cardiovascular, renal, neuroprotective, antifungal, antifibrotic, and anticancer effects. Accumulating evidence supports the pharmacological activities of Hyp in improving liver pathophysiology. Hence, the present literature review aims to summarize preclinical data suggesting the beneficial effects and underlying mechanisms of Hyp. In addition, our study focuses on hepatic antioxidant defense signaling to assess the underlying mechanisms of the biological actions of Hyp that are closely associated with liver diseases. Experimental findings from an up-to-date search showed that Hyp possesses hepatoprotective, antiviral, antisteatotic, anti-inflammatory, antifibrotic, and anticancer activities in cellular and animal models related to liver dysfunction by enhancing antioxidant responses. In particular, hepatocellular antioxidant defense via activation of erythroid-related nuclear factor 2 by Hyp chiefly explains how this compound acts as a therapeutic agent in liver diseases. Thus, this review emphasizes the therapeutic potential of Hyp as a strong antioxidative substance that plays a crucial role in the regulation of various liver disorders during their pathogenesis."]}, "AuthorList": [{"Identifier": ["0000-0002-9992-3942"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, College of Korean Medicine, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, Kyung Hee University Korean Medicine Hospital, 23, Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea."}], "LastName": "Jang", "ForeName": "Eungyeong", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The author declares no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Moon A.M., Singal A.G., Tapper E.B. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin. Gastroenterol. Hepatol. 2020;18:2650\u20132666. doi: 10.1016/j.cgh.2019.07.060.", "ArticleIdList": ["10.1016/j.cgh.2019.07.060", "PMC7007353", "31401364"]}, {"Citation": "Asrani S.K., Larson J.J., Yawn B., Therneau T.M., Kim W.R. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375\u2013382. doi: 10.1053/j.gastro.2013.04.005.", "ArticleIdList": ["10.1053/j.gastro.2013.04.005", "PMC3890240", "23583430"]}, {"Citation": "Oztumer C.A., Chaudhry R.M., Alrubaiy L. Association between behavioural risk factors for chronic liver disease and transient elastography measurements across the UK: A cross-sectional study. BMJ Open Gastroenterol. 2020;7:e000524. doi: 10.1136/bmjgast-2020-000524.", "ArticleIdList": ["10.1136/bmjgast-2020-000524", "PMC7678228", "33214232"]}, {"Citation": "Lin C., Huang X., Liu H., Wang Y. Interactions of hepatitis B virus infection with nonalcoholic fatty liver disease: Possible mechanisms and clinical impact. Dig. Dis. Sci. 2015;60:3513\u20133524. doi: 10.1007/s10620-015-3772-z.", "ArticleIdList": ["10.1007/s10620-015-3772-z", "26112990"]}, {"Citation": "Younossi Z., Henry L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology. 2016;150:1778\u20131785. doi: 10.1053/j.gastro.2016.03.005.", "ArticleIdList": ["10.1053/j.gastro.2016.03.005", "26980624"]}, {"Citation": "Singal A.K., Jampana S.C., Weinman S.A. Antioxidants as therapeutic agents for liver disease. Liver Int. 2011;31:1432\u20131448. doi: 10.1111/j.1478-3231.2011.02604.x.", "ArticleIdList": ["10.1111/j.1478-3231.2011.02604.x", "PMC3228367", "22093324"]}, {"Citation": "Ma Y., Lee G., Heo S.Y., Roh Y.S. Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease. Antioxidants. 2021;11:91. doi: 10.3390/antiox11010091.", "ArticleIdList": ["10.3390/antiox11010091", "PMC8772974", "35052595"]}, {"Citation": "Cederbaum A.I., Lu Y., Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch. Toxicol. 2009;83:519\u2013548. doi: 10.1007/s00204-009-0432-0.", "ArticleIdList": ["10.1007/s00204-009-0432-0", "19448996"]}, {"Citation": "Villanueva-Paz M., Mor\u00e1n L., L\u00f3pez-Alc\u00e1ntara N., Freixo C., Andrade R.J., Lucena M.I., Cubero F.J. Oxidative stress in drug-induced liver injury (DILI): From mechanisms to biomarkers for use in clinical practice. Antioxidants. 2021;10:390. doi: 10.3390/antiox10030390.", "ArticleIdList": ["10.3390/antiox10030390", "PMC8000729", "33807700"]}, {"Citation": "Li S., Tan H.Y., Wang N., Zhang Z.J., Lao L., Wong C.W., Feng Y. The role of oxidative stress and antioxidants in liver diseases. Int. J. Mol. Sci. 2015;16:26087\u201326124. doi: 10.3390/ijms161125942.", "ArticleIdList": ["10.3390/ijms161125942", "PMC4661801", "26540040"]}, {"Citation": "Yuan W., Wang J., An X., Dai M., Jiang Z., Zhang L., Yu S., Huang X. UPLC-MS/MS Method for the Determination of Hyperoside and Application to Pharmacokinetics Study in Rat After Different Administration Routes. Chromatographia. 2021;84:249\u2013256. doi: 10.1007/s10337-020-04002-x.", "ArticleIdList": ["10.1007/s10337-020-04002-x", "PMC7810192", "33487663"]}, {"Citation": "Pei J., Chen A., Zhao L., Cao F., Ding G., Xiao W. One-pot synthesis of hyperoside by a three-enzyme cascade using a UDP-galactose regeneration system. J. Agric. Food Chem. 2017;65:6042\u20136048. doi: 10.1021/acs.jafc.7b02320.", "ArticleIdList": ["10.1021/acs.jafc.7b02320", "28660766"]}, {"Citation": "Falco M.R., de Vries J.X. Isolation of hyperoside (quercetin-3-D-galactoside) from the flowers of acacia melanoxylon. Naturwissenschaften. 1964;51:462\u2013463. doi: 10.1007/BF00603768.", "ArticleIdList": ["10.1007/BF00603768"]}, {"Citation": "Wang Q., Wei H.C., Zhou S.J., Li Y., Zheng T.T., Zhou C.Z., Wan X.H. Hyperoside: A review on its sources, biological activities, and molecular mechanism. Phytother. Res. 2022;36:2779\u20132802. doi: 10.1002/ptr.7478.", "ArticleIdList": ["10.1002/ptr.7478", "35561084"]}, {"Citation": "Fu T., Wang L., Jin X., Sui H., Liu Z., Jin Y. Hyperoside induces both autophagy and apoptosis in non-small cell lung cancer cells in vitro. Acta Pharmacol. Sin. 2016;37:505\u2013518. doi: 10.1038/aps.2015.148.", "ArticleIdList": ["10.1038/aps.2015.148", "PMC4820797", "26948085"]}, {"Citation": "Xiao R., Xiang A.L., Pang H.B., Liu K.Q. Hyperoside protects against hypoxia/reoxygenation induced injury in cardiomyocytes by suppressing the Bnip3 expression. Gene. 2017;629:86\u201391. doi: 10.1016/j.gene.2017.07.063.", "ArticleIdList": ["10.1016/j.gene.2017.07.063", "28754633"]}, {"Citation": "Zhang Y., Yu X., Wang M., Ding Y., Guo H., Liu J., Cheng Y. Hyperoside from Z. bungeanum leaves restores insulin secretion and mitochondrial function by regulating pancreatic cellular redox status in diabetic mice. Free Radic. Biol Med. 2021;162:412\u2013422. doi: 10.1016/j.freeradbiomed.2020.10.320.", "ArticleIdList": ["10.1016/j.freeradbiomed.2020.10.320", "33161043"]}, {"Citation": "De Bruyn F., Van Brempt M., Maertens J., Van Bellegem W., Duchi D., De Mey M. Metabolic engineering of Escherichia coli into a versatile glycosylation platform: Production of bio-active quercetin glycosides. Microb. Cell Fact. 2015;14:138. doi: 10.1186/s12934-015-0326-1.", "ArticleIdList": ["10.1186/s12934-015-0326-1", "PMC4573293", "26377568"]}, {"Citation": "Chen H., Jiang F., Ding X., Liu D., Li M. Optimization of extraction technology for hyperoside, isoquercitrin, quercetin in Abelmoschus manihot (L.) Medic.by response surface method. Sci. Technol. Food Ind. 2015;24:216\u2013221."}, {"Citation": "Qiu Y., Wang M.Z. Isolation and Identification of Hyperoside in Abelmoschus manihot Flower. Adv. Mat. Res. 2013;781:880\u2013883. doi: 10.4028/www.scientific.net/AMR.781-784.880.", "ArticleIdList": ["10.4028/www.scientific.net/AMR.781-784.880"]}, {"Citation": "He F., Li D., Wang D., Deng M. Extraction and purification of Quercitrin, Hyperoside, Rutin, and Afzelin from Zanthoxylum Bungeanum maxim leaves using an aqueous two-phase system. J. Food Sci. 2016;81:C1593\u2013C1602. doi: 10.1111/1750-3841.13331.", "ArticleIdList": ["10.1111/1750-3841.13331", "27240023"]}, {"Citation": "Mapoung S., Umsumarng S., Semmarath W., Arjsri P., Srisawad K., Thippraphan P., Yodkeeree S., Dejkriengkraikul P. Photoprotective Effects of a Hyperoside-Enriched Fraction Prepared from Houttuynia cordata Thunb. on Ultraviolet B-Induced Skin Aging in Human Fibroblasts through the MAPK Signaling Pathway. Plants. 2021;10:2628. doi: 10.3390/plants10122628.", "ArticleIdList": ["10.3390/plants10122628", "PMC8708340", "34961096"]}, {"Citation": "\u00c7\u03b9rak C., Radu\u0161ien\u0117 J., Janulis V., Ivanauskas L. Secondary metabolites in Hypericum perfoliatum: Variation among plant parts and phenological stages. Bot. Helv. 2007;117:29\u201336. doi: 10.1007/s00035-007-0777-z.", "ArticleIdList": ["10.1007/s00035-007-0777-z"]}, {"Citation": "Camas N., Radusiene J., Stanius Z., Caliskan O., Cirak C. Secondary Metabolites of Hypericum leptophyllum Hochst., an Endemic Turkish Species. Sci. World J. 2012;2012:501027. doi: 10.1100/2012/501027.", "ArticleIdList": ["10.1100/2012/501027", "PMC3353281", "22649295"]}, {"Citation": "Liu J., Zhang Z., Yang L., Fan Y., Liu Y. Molecular structure and spectral characteristics of hyperoside and analysis of its molecular imprinting adsorption properties based on density functional theory. J. Mol. Graph. 2019;88:228\u2013236. doi: 10.1016/j.jmgm.2019.01.005.", "ArticleIdList": ["10.1016/j.jmgm.2019.01.005", "30772653"]}, {"Citation": "Sa\u00e7\u0131c\u0131 E., Yesilada E. Development of new and validated HPTLC methods for the qualitative and quantitative analysis of hyperforin, hypericin and hyperoside contents in Hypericum species. Phytochem. Anal. 2022;33:355\u2013364. doi: 10.1002/pca.3093.", "ArticleIdList": ["10.1002/pca.3093", "34734668"]}, {"Citation": "Guo A., Huanng Z., Liu C. Pharmacokinetic study on hyperoside in Beagle\u2019s dogs. Chin. Herb. Med. 2012;4:213\u2013217."}, {"Citation": "Chang Q., Zuo Z., Chow M.S., Ho W.K. Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats. Eur. J. Pharm. Biopharm. 2005;59:549\u2013555. doi: 10.1016/j.ejpb.2004.10.004.", "ArticleIdList": ["10.1016/j.ejpb.2004.10.004", "15760736"]}, {"Citation": "Zhang X., Su J., Wang X., Wang X., Liu R., Fu X., Li Y., Xue J., Li X., Zhang R. Preparation and Properties of Cyclodextrin Inclusion Complexes of Hyperoside. Molecules. 2022;27:2761. doi: 10.3390/molecules27092761.", "ArticleIdList": ["10.3390/molecules27092761", "PMC9100073", "35566111"]}, {"Citation": "Corless J.K., Middleton H.M. Normal liver function: A basis for understanding hepatic disease. Arch. Intern. Med. 1983;143:2291\u20132294. doi: 10.1001/archinte.1983.00350120085018.", "ArticleIdList": ["10.1001/archinte.1983.00350120085018", "6360063"]}, {"Citation": "Jaeschke H., Gores G.J., Cederbaum A.I., Hinson J.A., Pessayre D., Lemasters J.J. Mechanisms of hepatotoxicity. Toxicol. Sci. 2002;65:166\u2013176. doi: 10.1093/toxsci/65.2.166.", "ArticleIdList": ["10.1093/toxsci/65.2.166", "11812920"]}, {"Citation": "Dash R.P., Kala M., Nivsarkar M., Babu R.J. Implication of formulation strategies on the bioavailability of selected plant-derived hepatoprotectants. Crit. Rev. Ther. Drug Carr. Syst. 2017;34:489\u2013526. doi: 10.1615/CritRevTherDrugCarrierSyst.2017019623.", "ArticleIdList": ["10.1615/CritRevTherDrugCarrierSyst.2017019623", "29256835"]}, {"Citation": "Ram V.J., Goel A. Past and present scenario of hepatoprotectants. Curr. Med. Chem. 1999;6:217\u2013254. doi: 10.2174/0929867306666220208205735.", "ArticleIdList": ["10.2174/0929867306666220208205735", "10219101"]}, {"Citation": "Choi J.H., Kim D.W., Yun N., Choi J.S., Islam M.N., Kim Y.S., Lee S.M. Protective effects of hyperoside against carbon tetrachloride-induced liver damage in mice. J. Nat. Prod. 2011;74:1055\u20131060. doi: 10.1021/np200001x.", "ArticleIdList": ["10.1021/np200001x", "21428416"]}, {"Citation": "Zou L., Chen S., Li L., Wu T. The protective effect of hyperoside on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. Exp. Toxicol. Pathol. 2017;69:451\u2013460. doi: 10.1016/j.etp.2017.04.001.", "ArticleIdList": ["10.1016/j.etp.2017.04.001", "28434817"]}, {"Citation": "Xing H., Fu R., Cheng C., Cai Y., Wang X., Deng D., Gong X., Chen J. Hyperoside protected against oxidative stress-induced liver injury via the PHLPP2-AKT-GSK-3\u03b2 signaling pathway in vivo and in vitro. Front. Pharmacol. 2020;11:1065. doi: 10.3389/fphar.2020.01065.", "ArticleIdList": ["10.3389/fphar.2020.01065", "PMC7379337", "32765271"]}, {"Citation": "Cai Y., Li B., Peng D., Wang X., Li P., Huang M., Xing H., Chen J. Crm1-Dependent Nuclear Export of Bach1 is Involved in the Protective Effect of Hyperoside on Oxidative Damage in Hepatocytes and CCl4-induced Acute Liver Injury. J. Inflamm. Res. 2021;14:551\u2013565. doi: 10.2147/JIR.S279249.", "ArticleIdList": ["10.2147/JIR.S279249", "PMC7920627", "33658828"]}, {"Citation": "Huang C., Yang Y., Li W.X., Wu X.Q., Li X.F., Ma T.T., Zhang L., Meng X.M., Li J. Hyperin attenuates inflammation by activating PPAR-\u03b3 in mice with acute liver injury (ALI) and LPS-induced RAW264.7 cells. Int. Immunopharmacol. 2015;29:440\u2013447. doi: 10.1016/j.intimp.2015.10.017.", "ArticleIdList": ["10.1016/j.intimp.2015.10.017", "26526086"]}, {"Citation": "Qiao J., Wang B., Li Y., Bai M., Miao M. Protective effects of hyperoside on acute alcohol-inducing liver injury in mice. Zhongguo Zhong Yao Za Zhi. 2017;33:30\u201333."}, {"Citation": "Huang M., Chen J., Hu X., Xia P., Cai Y., Wang Q. Effect of hyperin on acute liver injury in rats against oxidative stress-induced by CCl4. Jujie Shushuxue Za Zhi. 2013;6:588\u2013590."}, {"Citation": "Mun S., Ryu H., Choi J. Inhibition effects of Zanthoxylum schinifolium and its active principle on lipid peroxidation and liver damage in carbon tetrachloride-treated mice. J. Korean Soc. Food Sci. Nutr. 1997;26:943\u2013951."}, {"Citation": "Ito M., Shimura H., Watanabe N., Tamai M., Hanada K., Takahashi A., Tanaka Y., Arai I., Zhang P.L., Rao C. Hepatorotective Compounds from Canarium album and Euphorbia nematocypha. Chem. Pharm. Bull. 1990;38:2201\u20132203.", "ArticleIdList": ["2279282"]}, {"Citation": "Xing H.Y., Cai Y.Q., Wang X.F., Wang L.L., Li P., Wang G.Y., Chen J.H. The cytoprotective effect of hyperoside against oxidative stress is mediated by the Nrf2-ARE signaling pathway through GSK-3\u03b2 inactivation. PLoS ONE. 2015;10:e0145183. doi: 10.1371/journal.pone.0145183.", "ArticleIdList": ["10.1371/journal.pone.0145183", "PMC4682950", "26674355"]}, {"Citation": "Choi S.J., Tai B.H., Cuong N.M., Kim Y.H., Jang H.D. Antioxidative and anti-inflammatory effect of quercetin and its glycosides isolated from mampat (Cratoxylum formosum) Food Sci. Biotechnol. 2012;21:587\u2013595. doi: 10.1007/s10068-012-0075-4.", "ArticleIdList": ["10.1007/s10068-012-0075-4"]}, {"Citation": "Abd Rashid N., Abd Halim S.A.S., Teoh S.L., Budin S.B., Hussan F., Ridzuan N.R.A., Jalil N.A.A. The role of natural antioxidants in cisplatin-induced hepatotoxicity. Biomed. Pharmacother. 2021;144:112328. doi: 10.1016/j.biopha.2021.112328.", "ArticleIdList": ["10.1016/j.biopha.2021.112328", "34653753"]}, {"Citation": "Lee S.S., Buters J.T., Pineau T., Fernandez-Salguero P., Gonzalez F.J. Role of CYP2E1 in the Hepatotoxicity of Acetaminophen. J. Biol. Chem. 1996;271:12063\u201312067. doi: 10.1074/jbc.271.20.12063.", "ArticleIdList": ["10.1074/jbc.271.20.12063", "8662637"]}, {"Citation": "Liou G.G., Hsieh C.C., Lee Y.J., Li P.H., Tsai M.S., Li C.T., Wang S.H. N-Acetyl cysteine overdose inducing hepatic steatosis and systemic inflammation in both propacetamol-induced hepatotoxic and normal mice. Antioxidants. 2021;10:442. doi: 10.3390/antiox10030442.", "ArticleIdList": ["10.3390/antiox10030442", "PMC8000488", "33809388"]}, {"Citation": "Niu C., Ma M., Han X., Wang Z., Li H. Hyperin protects against cisplatin-induced liver injury in mice. Acta Cir. Bras. 2017;32:633\u2013640. doi: 10.1590/s0102-865020170080000005.", "ArticleIdList": ["10.1590/s0102-865020170080000005", "28902939"]}, {"Citation": "Jiang Z., Wang J., Liu C., Wang X., Pan J. Hyperoside alleviated N-acetyl-para-amino-phenol-induced acute hepatic injury via Nrf2 activation. Int. J. Clin. Exp. Pathol. 2019;12:64\u201376.", "ArticleIdList": ["PMC6944033", "31933721"]}, {"Citation": "Xie W., Jiang Z., Wang J., Zhang X., Melzig M.F. Protective effect of hyperoside against acetaminophen (APAP) induced liver injury through enhancement of APAP clearance. Chem.-Biol. Interact. 2016;246:11\u201319. doi: 10.1016/j.cbi.2016.01.004.", "ArticleIdList": ["10.1016/j.cbi.2016.01.004", "26772156"]}, {"Citation": "Hu C., Chen Y., Cao Y., Jia Y., Zhang J. Metabolomics analysis reveals the protective effect of quercetin-3-O-galactoside (Hyperoside) on liver injury in mice induced by acetaminophen. J. Food Biochem. 2020;44:e13420. doi: 10.1111/jfbc.13420.", "ArticleIdList": ["10.1111/jfbc.13420", "32744346"]}, {"Citation": "An R.B., Kim H.C., Tian Y.H., Kim Y.C. Free radical scavenging and hepatoprotective constituents from the leaves of Juglans sinensis. Arch. Pharm. Res. 2005;28:529\u2013533. doi: 10.1007/BF02977753.", "ArticleIdList": ["10.1007/BF02977753", "15974437"]}, {"Citation": "Zhang Y., Wang M., Dong H., Yu X., Zhang J. Anti-hypoglycemic and hepatocyte-protective effects of hyperoside from Zanthoxylum bungeanum leaves in mice with high-carbohydrate/high-fat diet and alloxan-induced diabetes. Int. J. Mol. Med. 2018;41:77\u201386. doi: 10.3892/ijmm.2017.3211.", "ArticleIdList": ["10.3892/ijmm.2017.3211", "PMC5746319", "29115390"]}, {"Citation": "Wu L., Yang X., Huang Z., Liu H., Wu G. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta Pharmacol. Sin. 2007;28:404\u2013409. doi: 10.1111/j.1745-7254.2007.00510.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00510.x", "17303004"]}, {"Citation": "Guo X., Zhu C., Liu X., Ge Y., Jiang X., Zhao W. Hyperoside protects against heart failure-induced liver fibrosis in rats. Acta Histochem. 2019;121:804\u2013811. doi: 10.1016/j.acthis.2019.07.005.", "ArticleIdList": ["10.1016/j.acthis.2019.07.005", "31353051"]}, {"Citation": "Shen D., Hou J., Yuan F. Hyperoside suppresses injury in Mycoplasma pneumoniae pneumonia mice. Chin. J. Pathol. 2017;12:884\u2013889."}, {"Citation": "Shi Y., Qiu X., Dai M., Zhang X., Jin G. Hyperoside attenuates hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats. Transplant. Proc. 2019;51:2051\u20132059. doi: 10.1016/j.transproceed.2019.04.066.", "ArticleIdList": ["10.1016/j.transproceed.2019.04.066", "31399183"]}, {"Citation": "Lu X., Huang Z., Yang X., Wang H., Geng M., Li Z. Liver protective effects of hyperin on duck hepatitis B virus infection. Zhongguo Zhong Yao Za Zhi. 2007;23:10\u201312."}, {"Citation": "Guo X., Qu F., Xin Y., Wang J., Li H., Ma A., Zhao W. Effect and mechanism of hyperin on liver fibrosis in rats with heart failure. Shandong Yi Yao. 2021;61:40\u201345."}, {"Citation": "Abdelhameed R.F., Ibrahim A.K., Elfaky M.A., Habib E.S., Mahamed M.I., Mehanna E.T., Darwish K.M., Khodeer D.M., Ahmed S.A., Elhady S.S. Antioxidant and Anti-Inflammatory Activity of Cynanchum acutum L. Isolated Flavonoids Using Experimentally Induced Type 2 Diabetes Mellitus: Biological and In Silico Investigation for NF-\u03baB Pathway/miR-146a Expression Modulation. Antioxidants. 2021;10:1713. doi: 10.3390/antiox10111713.", "ArticleIdList": ["10.3390/antiox10111713", "PMC8615122", "34829584"]}, {"Citation": "Guan X., Zhao W., Min D., Liu C., Shang Y., Hu L. Protective effect of hyperoside on non-alcoholic fatty liver disease in ApoE-/- mice induced by high-fat diet. Drug Eval. Res. 2022;45:281\u2013286."}, {"Citation": "Huang K., Gen M., Wang J., Huang Z., Yang X., Chen H. Protective Effect of Hyperin on Immunological Liver Injury in Mice. Zhongguo Shiyan Fangjixue Zazhi. 2015;21:137\u2013141."}, {"Citation": "Xiong Q., Fan W., Tezuka Y., Adnyana I.K., Stampoulis P., Hattori M., Namba T., Kadota S. Hepatoprotective effect of Apocynum venetum and its active constituents. Planta Med. 2000;66:127\u2013133. doi: 10.1055/s-2000-11135.", "ArticleIdList": ["10.1055/s-2000-11135", "10763585"]}, {"Citation": "Saravanan S., Velu V., Nandakumar S., Madhavan V., Shanmugasundaram U., Murugavel K.G., Balakrishnan P., Kumarasamy N., Solomon S., Thyagarajan S.P. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J. Microbiol. Immunol. Infect. 2009;42:122\u2013128.", "ArticleIdList": ["19597643"]}, {"Citation": "Goyal A., Murray J.M. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology. PLoS ONE. 2014;9:e110143. doi: 10.1371/journal.pone.0110143.", "ArticleIdList": ["10.1371/journal.pone.0110143", "PMC4196970", "25313681"]}, {"Citation": "Geng M., Wang J.H., Chen H.Y., Yang X.B., Huang Z.M. Effects of hyperin on the cccDNA of duck hepatitis B virus and its immunological regulation. Yao Xue Xue Bao. 2009;44:1440\u20131444.", "ArticleIdList": ["21351483"]}, {"Citation": "Shen B., Wu N., Shen C., Zhang F., Wu Y., Xu P., Zhang L., Wu W., Lu Y., Han J. Hyperoside nanocrystals for HBV treatment: Process optimization, in vitro and in vivo evaluation. Drug Dev. Ind. Pharm. 2016;42:1772\u20131781. doi: 10.3109/03639045.2016.1173051.", "ArticleIdList": ["10.3109/03639045.2016.1173051", "27032257"]}, {"Citation": "Schreiner S., Nassal M. A role for the host DNA damage response in hepatitis B virus cccDNA formation\u2014and beyond? Viruses. 2017;9:125. doi: 10.3390/v9050125.", "ArticleIdList": ["10.3390/v9050125", "PMC5454437", "28531167"]}, {"Citation": "Rehman S., Ashfaq U.A., Ijaz B., Riazuddin S. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells. Microb. Pathog. 2018;121:198\u2013209. doi: 10.1016/j.micpath.2018.05.023.", "ArticleIdList": ["10.1016/j.micpath.2018.05.023", "29775725"]}, {"Citation": "Nguyen P., Leray V., Diez M., Serisier S., Bloc\u2019h J.L., Siliart B., Dumon H. Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. 2008;92:272\u2013283. doi: 10.1111/j.1439-0396.2007.00752.x.", "ArticleIdList": ["10.1111/j.1439-0396.2007.00752.x", "18477307"]}, {"Citation": "Ding W.X., Yang L. Alcohol and drug-induced liver injury: Metabolism, mechanisms, pathogenesis and potential therapies. Liver Res. 2019;3:129\u2013131. doi: 10.1016/j.livres.2019.11.006.", "ArticleIdList": ["10.1016/j.livres.2019.11.006", "PMC7164802", "32309012"]}, {"Citation": "Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006;43:S99\u2013S112. doi: 10.1002/hep.20973.", "ArticleIdList": ["10.1002/hep.20973", "16447287"]}, {"Citation": "Lian C.Y., Zhai Z.Z., Li Z.F., Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem.-Biol. Interact. 2020;330:109199. doi: 10.1016/j.cbi.2020.109199.", "ArticleIdList": ["10.1016/j.cbi.2020.109199", "32805210"]}, {"Citation": "Sun B., Zhang R., Liang Z., Fan A., Kang D. Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages. Int. Immunopharmacol. 2021;94:107438. doi: 10.1016/j.intimp.2021.107438.", "ArticleIdList": ["10.1016/j.intimp.2021.107438", "33611063"]}, {"Citation": "Duan J.Y., Chen W., Zhao Y.Q., He L.L., Li E.C., Bai Z.H., Wang Y.J., Zhang C.P. Flavonoids from Hypericum patulum enhance glucose consumption and attenuate lipid accumulation in HepG2 cells. J. Food Biochem. 2021;45:e13898. doi: 10.1111/jfbc.13898.", "ArticleIdList": ["10.1111/jfbc.13898", "34378802"]}, {"Citation": "Wang S., Sheng F., Zou L., Xiao J., Li P. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. J. Adv. Res. 2021;34:109\u2013122. doi: 10.1016/j.jare.2021.06.001.", "ArticleIdList": ["10.1016/j.jare.2021.06.001", "PMC8655136", "35024184"]}, {"Citation": "Robinson M.W., Harmon C., O\u2019Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 2016;13:267\u2013276. doi: 10.1038/cmi.2016.3.", "ArticleIdList": ["10.1038/cmi.2016.3", "PMC4856809", "27063467"]}, {"Citation": "Szabo G., Csak T. Inflammasomes in liver diseases. J. Hepatol. 2012;57:642\u2013654. doi: 10.1016/j.jhep.2012.03.035.", "ArticleIdList": ["10.1016/j.jhep.2012.03.035", "22634126"]}, {"Citation": "Tilg H., Kaser A., Moschen A.R. How to modulate inflammatory cytokines in liver diseases. Liver Int. 2006;26:1029\u20131039. doi: 10.1111/j.1478-3231.2006.01339.x.", "ArticleIdList": ["10.1111/j.1478-3231.2006.01339.x", "17032402"]}, {"Citation": "Petrescu A.D., DeMorrow S. Interleukin-24 therapy-a potential new strategy against liver fibrosis. EBioMedicine. 2021;65:103245. doi: 10.1016/j.ebiom.2021.103245.", "ArticleIdList": ["10.1016/j.ebiom.2021.103245", "PMC7921474", "33639397"]}, {"Citation": "Hernandez-Gea V., Friedman S.L. Pathogenesis of liver fibrosis. Annu. Rev. Pathol. 2011;6:425\u2013456. doi: 10.1146/annurev-pathol-011110-130246.", "ArticleIdList": ["10.1146/annurev-pathol-011110-130246", "21073339"]}, {"Citation": "Pinzani M., Rombouts K., Colagrande S. Fibrosis in chronic liver diseases: Diagnosis and management. J. Hepatol. 2005;42:S22\u2013S36. doi: 10.1016/j.jhep.2004.12.008.", "ArticleIdList": ["10.1016/j.jhep.2004.12.008", "15777570"]}, {"Citation": "Singh S., Fujii L.L., Murad M.H., Wang Z., Asrani S.K., Ehman R.L., Kamath P.S., Talwalkar J.A. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: A systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2013;11:1573\u20131584. doi: 10.1016/j.cgh.2013.07.034.", "ArticleIdList": ["10.1016/j.cgh.2013.07.034", "PMC3900882", "23954643"]}, {"Citation": "Wang J., Li J., Zhou Q., Zhang D., Bi Q., Wu Y., Huang W. Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis. Hepatol. Commun. 2018;2:467\u2013476. doi: 10.1002/hep4.1154.", "ArticleIdList": ["10.1002/hep4.1154", "PMC5880200", "29619424"]}, {"Citation": "Wang L., Yue Z., Guo M., Fang L., Bai L., Li X., Tao Y., Wang S., Liu Q., Zhi D. Dietary flavonoid hyperoside induces apoptosis of activated human LX-2 hepatic stellate cell by suppressing canonical NF-\u03baB signaling. Biomed. Res. Int. 2016;2016:1068528. doi: 10.1155/2016/1068528.", "ArticleIdList": ["10.1155/2016/1068528", "PMC4826685", "27110557"]}, {"Citation": "Fabregat I., Moreno-C\u00e0ceres J., S\u00e1nchez A., Dooley S., Dewidar B., Giannelli G., Ten Dijke P., Consortium I.L. TGF-\u03b2 signalling and liver disease. FEBS J. 2016;283:2219\u20132232. doi: 10.1111/febs.13665.", "ArticleIdList": ["10.1111/febs.13665", "26807763"]}, {"Citation": "Severi T., Van Malenstein H., Verslype C., Van Pelt J.F. Tumor initiation and progression in hepatocellular carcinoma: Risk factors, classification, and therapeutic targets. Acta Pharmacol. Sin. 2010;31:1409\u20131420. doi: 10.1038/aps.2010.142.", "ArticleIdList": ["10.1038/aps.2010.142", "PMC4003336", "20953207"]}, {"Citation": "EASL EASL clinical practice guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018;69:182\u2013236. doi: 10.1016/j.jhep.2018.03.019.", "ArticleIdList": ["10.1016/j.jhep.2018.03.019", "29628281"]}, {"Citation": "Mittal S., El-Serag H.B. Epidemiology of HCC: Consider the Population. J. Clin. Gastroenterol. 2013;47:S2\u2013S6. doi: 10.1097/MCG.0b013e3182872f29.", "ArticleIdList": ["10.1097/MCG.0b013e3182872f29", "PMC3683119", "23632345"]}, {"Citation": "Amarapurkar D. Asia-Pacific working party on prevention of hepatocellular carcinoma. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. J. Gastroenterol. Hepatol. 2009;24:955\u2013961. doi: 10.1111/j.1440-1746.2009.05805.x.", "ArticleIdList": ["10.1111/j.1440-1746.2009.05805.x", "19383082"]}, {"Citation": "Wei S., Sun Y., Wang L., Zhang T., Hu W., Bao W., Mao L., Chen J., Li H., Wen Y. Hyperoside suppresses BMP-7-dependent PI3K/AKT pathway in human hepatocellular carcinoma cells. Ann. Transl. Med. 2021;9:1233. doi: 10.21037/atm-21-2980.", "ArticleIdList": ["10.21037/atm-21-2980", "PMC8421975", "34532370"]}, {"Citation": "Jiang S., Xiong H., Wu H., Wen J., Liang L. Regulatory effect of hyperoside on proliferation and apoptosis of hepatic carcinoma cell HepG2 via mitochondrial P53/Caspase signaling pathway. Chin. J. Immunol. 2018;34:1832\u20131836."}, {"Citation": "Sattler F.R., Paolucci S., Kreider J.W., Ladda R.L. A human hepatoma cell line (PLC/PRF/5) produces lung metastases and secretes HBsAg in nude mice. Eur. J. Cancer Clin. Oncol. 1982;18:381\u2013389. doi: 10.1016/0277-5379(82)90010-4.", "ArticleIdList": ["10.1016/0277-5379(82)90010-4", "6889516"]}, {"Citation": "Han J., Meng J., Chen S., Wang X., Yin S., Zhang Q., Liu H., Qin R., Li Z., Zhong W. YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma. Cancer Res. 2019;79:1451\u20131464. doi: 10.1158/0008-5472.CAN-18-2238.", "ArticleIdList": ["10.1158/0008-5472.CAN-18-2238", "30760518"]}, {"Citation": "Xu S., Chen S., Xia W., Sui H., Fu X. Hyperoside: A Review of Its Structure, Synthesis, Pharmacology, Pharmacokinetics and Toxicity. Molecules. 2022;27:3009. doi: 10.3390/molecules27093009.", "ArticleIdList": ["10.3390/molecules27093009", "PMC9101560", "35566359"]}, {"Citation": "Ai G., Huang Z., Wang D., Zhang H. Acute toxicity and genotoxicity evaluation of hyperoside extracted from Abelmoschus manihot (L.) Medic. J. Chin. Pharm. Sci. 2012;21:477. doi: 10.5246/jcps.2012.05.063.", "ArticleIdList": ["10.5246/jcps.2012.05.063"]}, {"Citation": "Ai G., Huang Z., Wang D., Zhang H. Toxicity of hyperoside after long-term oral administration in Sistar rats. Chin. J. New Drugs. 2012;21:2811\u20132816."}, {"Citation": "Ai G., Wang D., Huang Z., Zhang H. Long-term toxicity of hyperoside in Beagle dogs. Chin. J. New Drugs. 2015;24:1641\u20131647."}, {"Citation": "Liu B., Tu Y., He W., Liu Y., Wu W., Fang Q., Tang H., Tang R., Wan Z., Sun W., et al. Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy. Aging. 2018;10:4197\u20134212. doi: 10.18632/aging.101723.", "ArticleIdList": ["10.18632/aging.101723", "PMC6326678", "30585174"]}, {"Citation": "Zhou J., Zhang S., Sun X., Lou Y., Yu J. Hyperoside protects HK-2 cells against high glucose-induced apoptosis and inflammation via the miR-499a-5p/NRIP1 pathway. Pathol. Oncol. Res. 2021;27:629829. doi: 10.3389/pore.2021.629829.", "ArticleIdList": ["10.3389/pore.2021.629829", "PMC8262192", "34257594"]}, {"Citation": "Ai G., Huang Z., Wang D., Liu Z. Study on toxicity of hyperoside in rat embryo-fetal development. Zhongguo Zhong Yao Za Zhi. 2012;37:2452\u20132455.", "ArticleIdList": ["23234148"]}, {"Citation": "Wei A., Song Y., Ni T., Xiao H., Wan Y., Ren X., Li H., Xu G. Hyperoside attenuates pregnancy loss through activating autophagy and suppressing inflammation in a rat model. Life Sci. 2020;254:117735. doi: 10.1016/j.lfs.2020.117735.", "ArticleIdList": ["10.1016/j.lfs.2020.117735", "32360572"]}, {"Citation": "Chen J.W., Zhu Z.Q., Hu T.X., Zhu D.Y. Structure-activity relationship of natural flavonoids in hydroxyl radical-scavenging effects. Acta Pharmacol. Sin. 2002;23:667\u2013672.", "ArticleIdList": ["12100765"]}, {"Citation": "Jang E., Kim B.J., Lee K.T., Inn K.S., Lee J.H. A survey of therapeutic effects of Artemisia capillaris in liver diseases. Evid. Based Complement. Alternat. Med. 2015;2015:728137. doi: 10.1155/2015/728137.", "ArticleIdList": ["10.1155/2015/728137", "PMC4558445", "26366183"]}, {"Citation": "Hyogo H., Yamagishi S. Advanced glycation end products (AGEs) and their involvement in liver disease. Curr. Pharm. Des. 2008;14:969\u2013972. doi: 10.2174/138161208784139701.", "ArticleIdList": ["10.2174/138161208784139701", "18473847"]}, {"Citation": "Zhang Z., Sethiel M.S., Shen W., Liao S., Zou Y. Hyperoside downregulates the receptor for advanced glycation end products (RAGE) and promotes proliferation in ECV304 cells via the c-Jun N-terminal kinases (JNK) pathway following stimulation by advanced glycation end-products in vitro. Int. J. Mol. Sci. 2013;14:22697\u201322707. doi: 10.3390/ijms141122697.", "ArticleIdList": ["10.3390/ijms141122697", "PMC3856085", "24252909"]}, {"Citation": "Zhou L., An X.F., Teng S.C., Liu J.S., Shang W.B., Zhang A.H., Yuan Y.G., Yu J.Y. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy. J. Med. Food. 2012;15:461\u2013468. doi: 10.1089/jmf.2011.1921.", "ArticleIdList": ["10.1089/jmf.2011.1921", "PMC3338104", "22439874"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "11"}, {"Year": "2022", "Month": "7", "Day": "21"}, {"Year": "2022", "Month": "7", "Day": "22"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "4", "Minute": "54"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "7", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["35892639", "PMC9331122", "10.3390/antiox11081437", "antiox11081437"]}}], "PubmedBookArticle": []}